Biolife Solutions (BLFS) Net Income towards Common Stockholders (2010 - 2025)

Biolife Solutions (BLFS) has 16 years of Net Income towards Common Stockholders data on file, last reported at $7.5 million in Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders fell 37.1% year-over-year to $7.5 million in Q4 2025; TTM through Mar 2026 was -$8.3 million, a 23.76% increase from a year earlier, with the FY2025 full-year figure at $7.5 million, up 166.88% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at $7.5 million, up from -$15.8 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for BLFS reached as high as $12.0 million in Q4 2024 and fell as low as -$72.9 million in Q2 2022.
• Historically, Net Income towards Common Stockholders has averaged -$12.6 million across 5 years, with a median of -$10.2 million in 2024.
• Across the five-year window, Net Income towards Common Stockholders plunged 13159.49% in 2022 and surged 189.52% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$15.7 million in 2021, then slumped by 212.41% to -$49.2 million in 2022, then jumped by 72.79% to -$13.4 million in 2023, then jumped by 189.52% to $12.0 million in 2024, then plunged by 37.1% to $7.5 million in 2025.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $7.5 million in Q4 2025, -$15.8 million in Q2 2025, and -$448000.0 in Q1 2025.